Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Company Benchmark – Nature Action 100
Nature Action 100 published the results of its first baseline assessments of the initiative's 100 companies at the United Nations…
Publication of the first guide to the Cali Fund
This guide, developed by the secretariat of the Convention on Biological Diversity, the United Nations Development Programme and the United…
Integrating biodiversity into private equity. Feedback and case studies
The integration of biodiversity issues by private capital actors is a major challenge, in response to new regulations and the…